Related Experiment Video
Updated: Jun 27, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients
Michael Heuser1, Anna Dolnik2, Isabell Arnhardt3
1Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Blood Advances
|June 25, 2026
Summary
A new low-coverage whole genome sequencing (lcWGS) method using long-read sequencing offers rapid and accurate cytogenetic profiling for acute myeloid leukemia (AML). This approach aids timely risk stratification and treatment decisions for AML patients.
Area of Science:
- Genomics
- Hematology
- Cancer Cytogenetics
Background:
- Acute myeloid leukemia (AML) diagnosis relies on chromosomal abnormalities for risk stratification and treatment planning.
- Conventional karyotyping is the gold standard but has lengthy turnaround times, delaying critical patient management.
- There is a need for faster, scalable methods for cytogenetic profiling in AML.
Purpose of the Study:
- To evaluate a long-read sequencing (LRS)-based low-coverage whole genome sequencing (lcWGS) approach as a rapid alternative for cytogenetic profiling in AML.
- To assess the analytical performance, reproducibility, and clinical utility of lcWGS for detecting chromosomal aberrations in AML.
Main Methods:
- Analysis of 100 diagnostic AML samples (50 retrospective, 50 prospective) using Oxford Nanopore Technology-based lcWGS.
- Comparison of lcWGS results with conventional cytogenetic assessments.
- Validation of reproducibility across two independent laboratories.
Main Results:
- LcWGS achieved 93% sensitivity, specificity, and overall accuracy in identifying chromosomal aberrations.
- Complex karyotypes were reliably detected (AUC 0.971), and results were highly reproducible (R=0.99).
- LcWGS identified complex karyotypes associated with shorter survival, similar to conventional methods, with a median turnaround time of ~34 hours for bioinformatics interpretation.
Conclusions:
- LcWGS is a rapid, reproducible, and accurate platform for detecting clinically relevant chromosomal abnormalities in AML.
- This method addresses the critical need for timely risk stratification and treatment initiation in AML patients.
- LcWGS shows significant potential to improve clinical management and patient outcomes in AML.
Related Concept Videos
01:17Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...